This inventor holds 2 USPTO granted patents and 8 published patent applications. Top assignee: Shaheen Innovations Holding Limited. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: The Innovations of Jeff Machovec: Pioneering Mist Inhaler Devices
Introduction: Jeff Machovec, an innovative inventor based in Rochester, MN, has made significant contributions to the field of inhalation therapy with his groundbreaking invention, the mist inhaler device. Known for its unique design and functionality, this device offers new therapeutic options for users in need of inhalation treatments.
Latest Patents: Jeff holds a patent for his mist inhaler device, designed specifically for generating a mist that includes a therapeutic agent for inhalation. The device comprises a mist generator and a driver device. The driver device is optimized to operate the mist generator at an ideal frequency, maximizing the efficiency of mist production. This invention not only enhances the delivery of medication but also improves user experience.
Career Highlights: Machovec works with Shaheen Innovations Holding Limited, where he focuses on developing cutting-edge healthcare technologies. His commitment to innovation and improving patient outcomes has established him as a respected figure in the medical device industry.
Collaborations: Throughout his career, Jeff has collaborated with talented professionals including Mohammed Alshaiba Saleh Ghannam Almazrouei and Sajid Bhatti. Together, they contribute their expertise to advance the development of mist inhalation technologies, helping to ensure effective treatment options for patients.
Conclusion: Jeff Machovec's contributions to inhalation therapy exemplify his dedication to innovation within the medical field. With a focus on enhancing therapeutic delivery through his patented mist inhaler device, he is poised to make a lasting impact on healthcare and improve the lives of many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile